This page shows the latest systemic lupus erythematosus news and features for those working in and with pharma, biotech and healthcare.
of systemic lupus erythematosus and ulcerative colitis. ... In addition, Amgen is testing its own IL-2 candidate – AMG-592 – in patients with systemic lupus erythematosus and chronic graft-versus-host disease.
Elsewhere in its pipeline, Viela has a number of candidates in ongoing or planned phase 1/2 development – including VIB4920 for Sjögren’s syndrome, VIB7734 for systemic lupus erythematosus (SLE) and
in infancy (SAVI) and a subset of systemic lupus erythematosus (SLE).
Last approved treatment for Lupus was GSK's Benlysta in 2011. Biogen’s experimental drug for systemic lupus erythematosus (SLE) has hit the mark in a phase 2 trial, adding to ... BIIB059 hit all its objectives in the LILAC study, including a
Will now decide whether to file treatment for approval. A year ago, prospects for AstraZeneca’s systemic lupus erythematosus treatment anifrolumab were being written off. ... Lupus is a disease in which the immune system attacks normal cells and tissues
That mechanism also forms the basis of Merck’s testing of evobrutinib in rheumatoid arthritis and systemic lupus erythematosus (SLE), also at the phase 2 stage.
More from news
Approximately 2 fully matching, plus 26 partially matching documents found.
A protocol change can work wonders – just ask AstraZeneca. In August, AstraZeneca’s systemic lupus erythematosus candidate anifrolumab achieved the primary efficacy endpoint in an amended trial called Tulip-2. ... Systemic lupus erythematosus is a
In a similar vein, Biogen Idec has sold its royalty rights to Benlysta (belimunab) for the treatment of systemic lupus erythematosus, to DRI Capital Managed Fund. ... Royalty monetisation. Benlysta (belimunab) for the treatment of systemic lupus
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
This product is SM101, which is being investigated for its use in the treatment of primary immune thrombocytopenia (ITP) and systemic lupus erythematosus (SLE).
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Examples abound, but systemic lupus erythematosus (SLE) – a disease for which there has only been one new drug approval since 1955 – is a notable case in point: while Black people account ... COVID has been like a magnifying glass, revealing systemic
systemic lupus erythematosus (SLE).
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....